Abstract
Cytokine release syndrome plays a crucial pathogenic role in COVID-19 pneumonia This pilot study provides the first evidence of the safety of anti-IL-1 treatment with highdose IV anakinra in 5 patients, who experienced a positive outcome
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have